Patients must be informed of the experimental nature of the study and its potential risks, and must sign an Institutional Review Board (IRB)-approved written informed consent form indicating such an understanding
Signed written Institutional Review Board (IRB)-approved informed consent document
Able to and provides Institutional Review Board (IRB) approved study specific written informed consent
Eligible and consent to the Institutional Review Board (IRB) 13-0002 registry trial protocol
Informed consent: All patients or their legal guardians (if the patient is <18 years of age) must sign an Ethics or institutional Review Board approved consent form indicating their awareness of the investigational nature and the risks of this study. When appropriate, younger patients will be included in all discussions in order to obtain assent.
Patients must sign Institutional Review Board (IRB) approved study specific informed consent
Ability to understand and provide signed informed consent that fulfills institutional review board (IRB)’s guidelines
Is willing to voluntarily sign and date an informed consent form that is approved by an institutional review board before the conduct of any study procedure
All subjects must have the ability to understand and the willingness to sign a written informed consent; signed informed consent form approved by the Institutional Review Board (IRB) is required; the patient, family member, and transplant staff physician (physician, nurse, and social worker) meet at least once prior to starting the transplant procedure; during this meeting, all pertinent information with respect to risks and benefits to the donor and recipient will be presented; alternative treatment modalities will be discussed
Patients must be informed of the experimental nature of the study and its potential risks, and must sign an Institutional Review Board (IRB)-approved written informed consent form indicating such an understanding
Signed informed consent approved by the Institutional Review Board
Willing to sign consent onto the Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking study, Institutional Review Board (IRB) number 15-000136 (blood draw optional)
have read, understood and signed the informed consent form (ICF) approved by the Institutional Review Board (IRB);
Patients must also provide written consent for biospecimens collection on Institutional Review Board (IRB) 08-000980
Written informed consent to participate in the study according to the investigational review board (IRB)
Must be fully informed regarding their illness and the investigational nature of the study protocol, and must sign an Institutional Review Board (IRB) approved Informed Consent Form (ICF).
Ability to understand the purposes and risks of the study and has signed a written informed consent form approved by the investigator’s Institutional Review Board (IRB)/Ethics Committee
Ability to understand the purposes and risks of the study and has signed a written informed consent form approved by the investigator’s Institutional Review Board (IRB)/Ethics Committee
Written consent on an Institutional Review Board-approved informed consent form prior to any study-specific evaluation
All subjects must have the ability to understand and the willingness to sign a written informed consent that has been approved by the City of Hope Institutional Review Board (COH IRB); the patient, a family member and transplant staff physician (physician, nurse, social worker) will meet at least once prior to the subject signing consent; during this meeting all pertinent information with respect to risks and benefits to donor and recipient will be presented; alternative treatment modalities will be discussed; the risks are explained in detail in the enclosed consent form
Ability to understand the purposes and risks of the study and has signed a written consent form approved by the investigator’s Institutional Review Board (IRB)/ethics committee
Study-specific informed consent approved for this purpose by the Institutional Review Board (IRB) of the University of Michigan indicating that they are aware of the investigational nature of the treatment and the potential risks must be signed by the patient
Ability to understand and provide signed informed consent that fulfills Institutional Review Board (IRB) guidelines
Signed informed consent approved by the Institutional Review Board
Patient is unwilling or unable to sign and date the Institutional Review Board (IRB) approved informed consent
Signed informed consent approved by the Institutional Review Board prior to patient entry
Patients must be informed of the experimental nature of the study and its potential risks, and must sign an Institutional Review Board (IRB)-approved written informed consent form indicating such an understanding
Signed informed consent approved by the Institutional Review Board prior to patient entry
Patients must voluntarily provide written Institutional Review Board (IRB)-approved informed consent
Patients will sign an Institutional Review Board (IRB)-approved informed consent form prior to any study-related procedures
Ability to understand the purposes and risks of the study and has signed a written informed consent form approved by the investigator’s Institutional Review Board (IRB)/Ethics Committee
Signed informed consent approved by the Institutional Review Board
Relapsed/refractory MCL: Understand and voluntarily sign an Institutional Review Board (IRB)-approved informed consent form
Understanding and voluntarily signing an Institutional Review Board (IRB)-approved informed consent form
Co-enrollment on Institutional Review Board (IRB) #98117, entitled Molecular Pathogenesis of Therapy-Related Leukemia, Dr. Armenian, principal investigator
Written informed consent and/or Consent waiver by institutional review board (IRB)
Institutional Review Board (IRB)-approved informed consent obtained and signed
Subjects must give institutional review board (IRB)-approved study-specific informed consent
Patients must have signed informed consent both for this study and the research use of data in the UAB bone marrow transplantation (BMT) program's Institutional Review Board (IRB) registered clinical database
FOR TISSUE COLLECTION TO ESTABLISH PDX (PART 1): Understand and voluntarily sign an Institutional Review Board (IRB)-approved informed consent form.
Signed, written Institutional Review Board (IRB)-approved informed consent form (ICF)
All patients or their legal guardians (if the patient is < 18 years old) must sign an Institutional Review Board (IRB)-approved document of informed consent to demonstrate their understanding of the investigational nature and the risks of this study before any protocol-related studies are performed; when appropriate, pediatric subjects will be included in all discussions
Patients must understand and be willing to sign an informed consent form approved for this purpose by the Institutional Review Board (IRB) of the University of Michigan Medical Center indicating that they are aware of the investigational aspects of the treatment and the potential risks
DONOR: The donor or legal guardian greater than 18 years of age, capable of signing an Institutional Review Board (IRB)-approved consent form
Willing to provide consent to Institutional Review Board (IRB) number (#) 521-93 and provide research tissue and blood specimens
All patients must be informed about the study and have signed a current Institutional Review Board (IRB) approved informed consent
Understanding and voluntary signing an institutional review board (IRB)-approved informed consent form
Patients must be informed of the experimental nature of the study and its potential risks and must sign an Institutional Review Board (IRB)-approved written informed consent form indicating such an understanding
Patients must exercise informed voluntary consent and sign a consent form approved by the University of Minnesota Institutional Review Board (IRB): Human Subjects Committee
Ability to understand and provide signed informed consent that fulfills Institutional Review Board (IRB)’s guidelines
Signed informed consent approved by the Institutional Review Board
Ability to understand the purposes and risks of the study and has signed a written informed consent form approved by the investigator's Institutional Review Board (IRB)/Ethics Committee
Written informed consent to participate in the study according to the Investigational Review Board (IRB)
Signed, Institutional Review Board (IRB)-approved written informed consent
Participants must sign the most current institutional review board (IRB)-approved study informed consent form (ICF)
Signed informed consent approved by the Institutional Review Board prior to patient entry
Signed informed consent approved by the Institutional Review Board prior to patient entry
Patients must be informed of the experimental nature of the study and its potential risks, and must sign an Institutional Review Board (IRB)-approved written informed consent form indicating such an understanding
Signed an Institutional Review Board (IRB)-approved informed consent document for this protocol
Signed an institutional review board (IRB)-approved informed consent document for this protocol
Optional participation in the microdose imaging trial, Institutional Review Board (IRB)#10-139
Patients must be informed of the experimental nature of the study and its potential risks and must sign an institutional review board (IRB)-approved written informed consent form indicating such an understanding
E 14. Absence of signed and dated Institutional Review Board (IRB)-approved participant informed consent form prior to enrollment into the study.
Signed, Institutional Review Board (IRB)-approved written informed consent
Signed, Institutional Review Board (IRB)-approved written informed consent
Ability to understand and provide signed informed consent approved by the Institutional Review Board prior to any study-related activities and within 30 days of first study dose
Patients must agree to randomization as documented by signing the Institutional Review Board (IRB) approved consent form
Patients or a legal guardian will sign an informed consent form approved by the Institutional Review Board (IRB) and obtained by the principal or a co-investigator before patient entry; minors will provide assent
Patients must sign an informed consent form approved for this purpose by the Institutional Review Board (IRB) of the University of Michigan Medical Center indicating that they are aware of the investigational aspects of the treatment and the potential risks
Signed and dated institutional review board (IRB)-approved informed consent before any protocol-specific screening procedures are performed.
Signed and dated Institutional Review Board (IRB)-approved consent form
Provide written informed consent for study participation, approved by the appropriate institutional review board (IRB), and be willing and able to cooperate with all aspects of the protocol;
Prospective study participants must be informed of the investigational nature of the study and must have signed an Institutional Review Board (IRB)-approved informed consent form in accordance with institutional and federal guidelines
Understanding and voluntary signing an Institutional Review Board (IRB)-approved informed consent form
Fully informed about their illness and the investigational nature of the study protocol and must sign and date an Institutional Review Board-approved Informed Consent Form
Absence of signed and dated Institutional Review Board-approved patient informed consent from prior to enrollment in the study
Competent to sign and date an Institutional Review Board approved informed consent form
Patients must have signed the current Institutional Review Board (IRB) approved informed consent prior to registration (see Informed Consent).
Institutional Review Board (IRB) approved, signed written informed consent
Enrollment within 6 weeks of tumor board review
Signed, Institutional Review Board (IRB)-approved written informed consent
Institutional review board (IRB) approved signed written informed consent
Signed informed consent approved by the Duke Institutional Review Board
Signed informed consent approved by the Institutional Review Board prior to patient entry
Institutional Review Board (IRB) approved, signed written informed consent
Institutional Review Board (IRB) approved signed written informed consent
Signed Institutional Review Board (IRB) approved written informed consent
All patients must sign an informed consent form approved for this purpose by the Institutional Review Board (IRB) of the University of Pennsylvania
Signed an Institutional Review Board (IRB)-approved informed consent
Signed written informed consent approved by the Institutional Review Board obtained prior to study entry
All subjects must have the ability to understand and the willingness to sign a written informed consent that has been approved by the City of Hope (COH) Institutional Review Board (IRB); the patient, a family member and transplant staff physician (physician, nurse, and social worker) will meet at least once prior to the subject signing consent; during this meeting all pertinent information with respect to risks and benefits to donor and recipient will be presented; alternative treatment modalities will be discussed; the risks are explained in detail in the enclosed consent form
The study has been explained to the patient/volunteer and the subject has signed the Institutional Review Board (IRB)-approved informed consent form prior to optical measurements
Able to and provides Institutional Review Board (IRB) approved study specific written informed consent
Are able to give written informed consent in a manner approved by the Institutional Review Board and comply with the requirements of the study.
Patient must consent to be in the study and must have signed and dated an Institutional Review Board (IRB) approved consent form conforming to federal and institutional guidelines
TNBC patients who are previously untreated and enrolled in the prospective Institutional Review Board (IRB) approved clinical trial: 2014-0185
Consent: patients must be able to give written, informed consent as approved by the local Institutional Review Board (IRB)
Have read and signed the Institutional Review Board (IRB)-approved informed consent form for participating in the study
Will sign the Institutional Review Board (IRB)-approved consent form
Women must be enrolled in Atlanta Women’s human immunodeficiency virus (HIV) Interagency Study (WIHS) (institutional review board [IRB] # 00062469)
PATIENT: Have read and signed the Institutional Review Board (IRB)-approved informed consent form for participating in the study
Patients must understand and be willing to sign an informed consent form approved for this purpose by the Institutional Review Board (IRB) of the University of Michigan Medical Center indicating that they are aware of the investigational aspects of the treatment and the potential risks
All patients or their legal guardians (if the patients is < 18 years old) must sign an Institutional Review Board (IRB)-approved document of informed consent to demonstrate their understanding of the investigational nature and the risks of this study before any protocol-related studies are performed; when appropriate, pediatric subjects will be included in all discussions
The study population may include illiterate persons and University Hospital (UH)/Case employees if they meet other inclusion criteria; the consent process for these potential participants will be conducted according to Institutional Review Board (IRB) guidelines
Written informed consent will be signed by the patients before the MRI based on the guidelines approved by the Ohio State University Institutional Review board
Signed, Institutional Review Board (IRB)-approved written informed consent
Institutional Review Board (IRB) written informed consent obtained and signed
Subjects must have signed Institutional Review Board (IRB)-approved informed consent documentation
Subjects must have signed an institutional review board (IRB)-approved informed consent document
Subjects (or their parent or legal guardian) must have signed Institutional Review Board (IRB)-approved assent/informed consent documentation
Ability to understand the purposes and risks of the study and has signed a written informed consent form approved by the investigator's Institutional Review Board (IRB)/Ethics Committee
Be Institutional Review Board (IRB)-approved and open to accrual at USC Norris
